Liver fibrosis score AARPRI predicts gynecological cancers in metabolic women

Rationale: Non-alcoholic fatty liver disease (NAFLD), specifically steatohepatitis (NASH) and fibrosis, represents a clinical manifestation of increased visceral adipose tissue amount and adiposopathy, whose pathogenetic features have been proposed as tumorigenic triggers.

Source: Clinical Nutrition ESPEN - December 1, 2023 Category: Nutrition Authors: L. Crudele, C. De Matteis, F. Novielli, S. Petruzzelli, M. Cariello, A. Moschetta Source Type: research